These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. A comparative review of current topical antibiotics for impetigo. Galindo E; Hebert AA Expert Opin Drug Saf; 2021 Jun; 20(6):677-683. PubMed ID: 33726585 [TBL] [Abstract][Full Text] [Related]
26. Ozenoxacin (Xepi) for the Treatment of Impetigo. Eudaley S Am Fam Physician; 2020 Jun; 101(12):760-761. PubMed ID: 32538600 [No Abstract] [Full Text] [Related]
27. Skin tissue exposure of once- versus twice-daily topical ozenoxacin 2% cream: a Phase I study in healthy volunteers. Gropper S; Albareda N; Santos B; Febbraro S Future Microbiol; 2014; 9(8 Suppl):S17-22. PubMed ID: 25209520 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections. Gisby J; Bryant J Antimicrob Agents Chemother; 2000 Feb; 44(2):255-60. PubMed ID: 10639346 [TBL] [Abstract][Full Text] [Related]
29. QbD Based Formulation Development and Optimisation of Ozenoxacin Topical Nano-Emulgel and Efficacy Evaluation Using Impetigo Mice Model. Ramireddy AR; Behara DK AAPS PharmSciTech; 2024 Apr; 25(5):90. PubMed ID: 38649513 [TBL] [Abstract][Full Text] [Related]
30. The safety and efficacy of topical retapamulin ointment versus placebo ointment in the treatment of secondarily infected traumatic lesions: a randomized, double-blind superiority study. Tomayko JF; Li G; Breton JJ; Scangarella-Oman N; Dalessandro M; Martin M Adv Skin Wound Care; 2013 Mar; 26(3):113-21. PubMed ID: 23426412 [TBL] [Abstract][Full Text] [Related]
31. Is penicillin still the drug of choice for non-bullous impetigo? Feder HM; Abrahamian LM; Grant-Kels JM Lancet; 1991 Sep; 338(8770):803-5. PubMed ID: 1681172 [No Abstract] [Full Text] [Related]
32. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children. Silverstein BE; Allaire C; Bateman KM; Gearinger LS; Morris TW; Comstock TL Clin Ther; 2011 Jan; 33(1):13-26. PubMed ID: 21397770 [TBL] [Abstract][Full Text] [Related]
34. Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial. Koning S; van Suijlekom-Smit LW; Nouwen JL; Verduin CM; Bernsen RM; Oranje AP; Thomas S; van der Wouden JC BMJ; 2002 Jan; 324(7331):203-6. PubMed ID: 11809642 [TBL] [Abstract][Full Text] [Related]
36. NVC-422 topical gel for the treatment of impetigo. Iovino SM; Krantz KD; Blanco DM; Fernández JA; Ocampo N; Najafi A; Memarzadeh B; Celeri C; Debabov D; Khosrovi B; Anderson M Int J Clin Exp Pathol; 2011 Aug; 4(6):587-95. PubMed ID: 21904634 [TBL] [Abstract][Full Text] [Related]
37. Topical Minocycline Foam for the Treatment of Impetigo in Children: Results of a Randomized, Double-Blind, Phase 2 Study. Chamny S; Miron D; Lumelsky N; Shalev H; Gazal E; Keynan R; Shemer A; Tamarkin D J Drugs Dermatol; 2016 Oct; 15(10):1238-1243. PubMed ID: 27741342 [TBL] [Abstract][Full Text] [Related]
38. Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children. Jacobs MR Future Microbiol; 2007 Dec; 2(6):591-600. PubMed ID: 18041900 [TBL] [Abstract][Full Text] [Related]
39. Retrospective Analysis of the Real-World Use of Topical Antimicrobials in the Paediatric Population with Impetigo in Italy: Focus on the Role of Ozenoxacin 1% Cream. Barbieri E; Cavagnis S; Boracchini R; Scamarcia A; Testa A; Ciarniello MG; Martinelli B; Cantarutti L; Giaquinto C; Cantarutti A Children (Basel); 2023 Mar; 10(3):. PubMed ID: 36980105 [TBL] [Abstract][Full Text] [Related]